Vaccine Lawsuit.pdf

Pfizer and Moderna, manufacturers of mRNA vaccines, are accused of unfair competition and deceptive practices by the plaintiff, who claims their vaccines are not safe and have caused financial damages. The plaintiff's product, OxySilver, uses the 528Hz frequency to neutralize pathogens and boost immunity, whereas the defendants' vaccines use bioelectronic lipid hydrogel devices to deliver DNA instructions. The defendants' testing protocols allegedly show no genetic safety testing was conducted prior to FDA authorization. The plaintiff claims the defendants have disparaged their product and engaged in unfair competition, causing restraint of trade and financial damages.

The defendants' mRNA vaccines use nano-bioelectronic technology, enabling biosynthesis and "transhumanism," which raises ethical, moral, and social concerns. The plaintiff became aware of the defendants' intentions to integrate their technology into vaccine hydrogel devices in 2019. The complaint alleges that the defendants hid their conspiracy to unfairly compete against the plaintiff, represented their approach as "novel," and disparaged the plaintiff's "528" industry and therapeutic technology.

The plaintiff's hospitalization for Haemophilus influenza pneumonia, which acquired severe pathogenicity through genetic recombination with the COVID virus, is cited as evidence of the genetic risk to society and "herd immunity" posed by the defendants' vaccines. The plaintiff has warned of the dangers of genetically engineered lab viruses and bioweapons in their books and films over the past quarter century. The case raises concerns about the safety and ethics of mRNA vaccines and the use of nano-bioelectronic technology in medicine.